BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

10 articles for K Nakajima

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Combined NK1 and NK2 tachykinin receptor antagonists: synthesis and structure-activity relationships of novel oxazolidine analogues.EBI
Sankyo
Discovery of diamide compounds as diacylglycerol acyltransferase 1 (DGAT1) inhibitors.EBI
Novartis Institutes For Biomedical Research
Discovery of CS-0777: A Potent, Selective, and Orally Active S1P1 Agonist.EBI
TBA
Novel orally bioavailable EZH1/2 dual inhibitors with greater antitumor efficacy than an EZH2 selective inhibitor.EBI
Daiichi Sankyo Co., Ltd
Combined tachykinin receptor antagonist: synthesis and stereochemical structure-activity relationships of novel morpholine analogues.EBI
Sankyo
Synthesis and 5 alpha-reductase inhibitory activities of benzofuran derivatives with a carbamoyl group.EBI
Sankyo
Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)/SMARCA4-Mutant Cancers.EBI
Novartis Institutes For Biomedical Research
Discovery of an Orally Bioavailable Benzimidazole Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor That Suppresses Body Weight Gain in Diet-Induced Obese Dogs and Postprandial Triglycerides in Humans.EBI
Novartis Institutes For Biomedical Research
KIT KINASE INHIBITORS AND METHODS OF USE THEREOFBDB
Deciphera Pharmaceuticals